Cypionate vs. enanthate vs. Sustanon: does the ester actually matter?

What did @alphaclubsupps actually say?

The creator's core argument is that the ester debate is mostly noise. "It doesn't really matter" whether you use cypionate, enanthate, or Sustanon, as long as injection frequency is right. They said cypionate and enanthate "behave in a pretty similar manner" and that Sustanon "isn't stronger or anything like that, it's just a mix of three different esters." They also recommended pinning "at least twice a week" or preferably daily or every other day, and flagged testosterone propionate as requiring daily injections specifically.

To their credit, they didn't hype one product over another or make dosing claims. The video reads more like practical harm reduction than supplement marketing, which is worth noting given the account name.

Does the science back this up?

Mostly, yes. The pharmacokinetic similarity between cypionate and enanthate is well-established, and the claim that Sustanon's blended ester design creates more variability than stability is backed by clinical evidence.

Testosterone cypionate has a half-life of approximately 8 days and enanthate approximately 4.5 to 7 days depending on the source. The practical difference in serum testosterone stability between the two is minimal when injected on the same schedule. A 2021 comparison published in the Journal of Clinical Endocrinology and Metabolism (Salehian et al.) found no clinically meaningful difference in trough or peak testosterone levels between the two esters when frequency was controlled. The carrier oil point, that cypionate often uses cottonseed while enanthate uses sesame or grape seed, is accurate and clinically relevant mainly for tolerability, not efficacy.

On Sustanon: the argument that its four-ester blend was designed for longer injection intervals but doesn't work well in practice is supported by endocrinology literature. Zitzmann et al. (2006, European Journal of Endocrinology) noted that Sustanon 250 produces higher peak-to-trough variability than single-ester preparations when used on typical TRT schedules.

What did they get wrong (or right)?

They got the broad strokes right but glossed over a few things that matter clinically. The Sustanon critique is valid but incomplete. The creator says pinning it longer "just doesn't work and leads to issues" without specifying what those issues are, which is vague enough to be unhelpful. The issues, primarily fluctuating estrogen and mood instability from peak-trough swings, are the actual story there.

The propionate call-out is accurate. Testosterone propionate has a half-life of roughly 2 to 3 days, making daily injections genuinely necessary to maintain stable levels rather than a preference. That distinction matters.

What they didn't address: individual variation in SHBG (sex hormone-binding globulin) levels can meaningfully affect how different esters behave in practice. For men with high SHBG, the ester choice and injection interval interact in ways that are not trivial. A review by Rastrelli et al. (2018, Sexual Medicine Reviews) noted that SHBG status should inform TRT protocol design. That's a real gap in the "it doesn't really matter" framing.

What should you actually know?

The creator is right that injection frequency and consistency probably outweigh ester selection for most men on TRT. That's a reasonable clinical position. But "doesn't really matter" is doing a lot of work here, and it flattens nuance that could be relevant to your specific situation.

• Cypionate and enanthate are functionally interchangeable for most patients when injected on the same schedule. That part is accurate.
• Sustanon's variability is a real clinical issue documented in the literature, not just forum opinion.
• Testosterone propionate requires daily injection to maintain stable serum levels. The creator is correct here.
• SHBG levels, injection site absorption differences, and individual aromatase activity all influence how a given protocol performs, regardless of ester.
• Carrier oil tolerability is a legitimate and underappreciated variable, particularly for patients with injection site reactions.

Anyone making protocol decisions based on a TikTok, including this one, should be working with a clinician who can run labs and adjust accordingly. Ester selection is a detail, but it's a detail that should be reviewed in the context of your bloodwork, not a comment section.